My research focuses on ways to improve prognosis of urological cancer, especially prostate cancer by targeting tumor metabolism. One main area of interest is drug repurposing . i.e. using established drugs of metabolic diseases against mechanisms driving cancer progression. The topic is approached in multidisciplinary way: promising interventions are evaluated in vitro, in retrospective epidemiological studies using FInnish nationwide registry data and finally in clinical studies.